Abstract
Objective: To evaluate the use of aerosolized magnesium sulfate (MgSO4) in combination with inhaled betaagonists compared to inhaled beta-agonists alone in the treatment of acute asthma. Methods: Published (1966-2005) randomized controlled trials were retrieved using different databases, bibliographic reviews of primary research, review articles, and citations from texts. The primary outcome measure was pulmonary function. Results: Five out of 16 potentially eligible studies met criteria for inclusion in the meta-analysis. They included 187 adults and 62 children who were treated in an emergency department. Patients that received MgSO4 showed non-significant improvement in pulmonary function (SMD = -0.21, 95%CI:-0.52 to 0.10, p = 0.18). The advantage of the use of MgSO4 was demonstrated only in patients with life-threatening acute asthma (baseline FEV1 or PEF < 30% predicted) (SMD = - 1.10; 95%CI: -1.80 to -0.39, p = 0.002; I2 = 0%). Nebulized MgSO4 with beta-agonists showed a marginal significant reduction in admission rate compared to beta-agonists alone (RR = 0.63, 95% CI: 0.39 to 1.01, p = 0.06, I2 = 0%). Conclusions: Data suggests that MgSO4 presents a beneficial effect in terms of pulmonary function only in the subgroup of life-threatening acute asthma patients. However, the small number of studies selected, the standard treatment used in all trials, and the beta-agonist delivery method restricts this conclusion.
Keywords: Magnesium sulphate, beta-agonists, acute severe asthma, emergency department treatment
Current Drug Therapy
Title: Is There a Place for Nebulized Magnesium Sulfate in the Treatment of Acute Asthma? A Systematic Review
Volume: 1 Issue: 2
Author(s): Gustavo J. Rodrigo and Luis J. Nannini
Affiliation:
Keywords: Magnesium sulphate, beta-agonists, acute severe asthma, emergency department treatment
Abstract: Objective: To evaluate the use of aerosolized magnesium sulfate (MgSO4) in combination with inhaled betaagonists compared to inhaled beta-agonists alone in the treatment of acute asthma. Methods: Published (1966-2005) randomized controlled trials were retrieved using different databases, bibliographic reviews of primary research, review articles, and citations from texts. The primary outcome measure was pulmonary function. Results: Five out of 16 potentially eligible studies met criteria for inclusion in the meta-analysis. They included 187 adults and 62 children who were treated in an emergency department. Patients that received MgSO4 showed non-significant improvement in pulmonary function (SMD = -0.21, 95%CI:-0.52 to 0.10, p = 0.18). The advantage of the use of MgSO4 was demonstrated only in patients with life-threatening acute asthma (baseline FEV1 or PEF < 30% predicted) (SMD = - 1.10; 95%CI: -1.80 to -0.39, p = 0.002; I2 = 0%). Nebulized MgSO4 with beta-agonists showed a marginal significant reduction in admission rate compared to beta-agonists alone (RR = 0.63, 95% CI: 0.39 to 1.01, p = 0.06, I2 = 0%). Conclusions: Data suggests that MgSO4 presents a beneficial effect in terms of pulmonary function only in the subgroup of life-threatening acute asthma patients. However, the small number of studies selected, the standard treatment used in all trials, and the beta-agonist delivery method restricts this conclusion.
Export Options
About this article
Cite this article as:
Rodrigo J. Gustavo and Nannini J. Luis, Is There a Place for Nebulized Magnesium Sulfate in the Treatment of Acute Asthma? A Systematic Review, Current Drug Therapy 2006; 1 (2) . https://dx.doi.org/10.2174/157488506776931003
DOI https://dx.doi.org/10.2174/157488506776931003 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs
Current Drug Metabolism Selective Inhibition of Phosphodiesterases 4A, B, C and D Isoforms in Chronic Respiratory Diseases: Current and Future Evidences
Current Pharmaceutical Design The Role of Antihistamines in the Management of Allergic Rhinitis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Identifying Patterns in Signs and Symptoms Preceding the Clinical Diagnosis of Alzheimer’s Disease: Retrospective Medical Record Review Study and a Nested Case-control Design
Current Alzheimer Research Drug Evolution Concept in Drug Design: 2. Chimera Method
Medicinal Chemistry Predicting Drug Efficacy Using Integrative Models for Chronic Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) An Update on NLRP3 Inflammasome Activation by Engineered Nanomaterials
Current Bionanotechnology (Discontinued) Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Susceptibility to Rhinovirus-induced Early Wheezing as a Risk Factor for Subsequent Asthma Development
Current Respiratory Medicine Reviews Transient Receptor Potential Vanilloid 1 Channel Modulation: A Novel Approach to Pain Therapy
Current Bioactive Compounds 2-Arylindoles: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activity
Current Medicinal Chemistry Association of Common Variants in the IL-33/ST2 Axis with Ischemic Stroke
Current Neurovascular Research Isolation, Characterization and Hypoglycemic Activity of an Acid Polysaccharide Isolated from Schisandra chinensis (Turcz.) Baill
Letters in Organic Chemistry Poly-Pharmacy Among the Elderly: Analyzing the Co-Morbidity of Hypertension and Diabetes
Current Pharmaceutical Design Formaldehyde Levels in Fabrics on the Ghanaian Market
Current Materials Science Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Exhaled Nitric Oxide in COPD
Current Respiratory Medicine Reviews TRPM8 Biology and Medicinal Chemistry
Current Topics in Medicinal Chemistry Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design